Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Research progress on multiple myeloma immunophenotyping and minimal residual disease detected by flow cytometry].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2015

Li Han-Qing, Zhai Yong-Ping

Abstract excerpt

Multiple myeloma (MM) is a haematological malignancy characterized by the accumulation of monoclonal plasma cells in the bone marrow and remained incurable. Flow cytometry has been widely used in the detection of immunophenotype and minimal residual disease, diagnosis, monitoring and prognosis of MM. Normal plasma cells and malignant plasma cells can be distinguished according to different cell surface antigen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to Flow Cytometry
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multiple Myeloma

Share to Neoplasm, Residual

Share to Phenotype

Share to Plasma Cells

Share to Prognosis

Source

Identifiers

PMID: 25687080
DOI: 10.7534/j.issn.1009-2137.2015.01.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Research progress on multiple myeloma immunophenotyping and minimal residual disease detected by flow cytometry].PMID 25687080Read ↗

Applications of Multiparameter Flow Cytometry in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma PatientsSemantic proximity Read ↗

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.Semantic proximity Read ↗

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future PerspectivesSemantic proximity Read ↗

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read ↗

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment.Semantic proximity Read ↗

High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.Semantic proximity Read ↗

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.Semantic proximity Read ↗

Multiple Myeloma: Heterogeneous in Every WaySemantic proximity Read ↗

Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myelomaSemantic proximity Read ↗

Molecular detection of minimal residual disease in multiple myelomaSemantic proximity Read ↗

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.Semantic proximity Read ↗

[New treatment and diagnostic test for multiple myeloma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.